O
Ossio
An orthopedic medical device company founded in Israel in 2014 with the vision to completely transform the orthopedic experience for physicians, patients, and payors
About Ossio
OSSIO is a pioneering company in the orthopedic fixation market, focusing on biointegrative implants that encourage natural bone healing. Headquartered in Caesarea, Israel, with commercial operations in Boston, Massachusetts, OSSIO aims to set the gold standard in orthopedic fixation by eliminating the need for hardware removal procedures, reducing implant-related complications, and improving overall healthcare economics in orthopedics. The company's proprietary implant material combines the strength necessary for functional fixation with the ability to fully integrate into the native anatomy without causing adverse inflammation. This innovative technology allows surgeons to offer secure, all-natural bone repair solutions that patients prefer. OSSIO serves a wide range of clients, including orthopedic surgeons, healthcare providers, and payors, operating primarily in the medical device and healthcare sectors. The business model revolves around the sale of its unique implants and disposable, sterile instruments, leveraging existing reimbursement and surgical techniques to facilitate adoption. Revenue is generated through the direct sale of these products to healthcare institutions and providers.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Woburn, United States
- Employees
- 166
- Open positions
- None listed
- Dealroom signal
- 89.7/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Biodegradable, Orthopedic, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Feb 2026 | $40M | — | Monroe Capital · Horizon Technology Finance Corporation | ↗ |
| LATE VCOther financing | Dec 2024 | $28M | $193M | MVM Life Science Partners · Courage Capital Management · OCV Partners · Questa Capital Management | ↗ |
Growth signals
Latest recorded traffic for Ossio is 12K monthly website visits, up 34.8% over the last three months. Ossio's team grew 15.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Secocha Ventures
OurCrowd
Series A1 investor entered at this stage
OCV Partners
Series B and later5 investors entered at this stage
Courage Capital Management
MVM Life Science Partners
Questa Capital Management
Monroe Capital
Horizon Technology Finance Corporation
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ossio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ossio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.